Today ScienceDaily reported on a study published in Bioorganic and Medicinal Chemistry by researchers at Brown University that identifies the potential for a new compound in treating bacterial infections, specifically those that are drug-resistant.
Antibiotic resistance is becoming increasingly worrisome as strains like MRSA become household words and bacteria evolve new genetic mechanisms against treatment.
One antibiotic, which means a compound that acts against bacteria (and only bacteria - antibiotics cannot fight viral infections like a cold or the flu), is chloramphenicol. The new compound, BU-005, prevents bacteria from pumping this antibiotic out of their cellular structure, leaving the bacterial cell susceptible to the agent.
The research team used the same synthesis method for other types of compounds that may make headlines in the near future.